Waverley Pharma Inc. (FRA:5GZ)
Germany · Delayed Price · Currency is EUR 0.0060
0.00 (0.00%)
Last updated: Nov 28, 2025, 9:59 AM CET
Waverley Pharma Company Description
Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom.
The company develops poly ADP-ribose polymerase-1 (PARP-1) inhibitors for cancer treatment. It also operates a retail pharmacy in the United States.
Waverley Pharma Inc. was founded in 2014 and is headquartered in Winnipeg, Canada.
Waverley Pharma Inc.
| Country | Canada |
| Founded | 2014 |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | Larry Thiessen |
Contact Details
Address: 4-1250 Waverley Street Winnipeg, R3T 6C6 Canada | |
| Website | waverleypharma.com |
Stock Details
| Ticker Symbol | 5GZ |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Larry Thiessen | Chief Executive Officer |
| Haaris Uddin | Chief Financial Officer |